Invertebrate Models Untangle the Mechanism of Neurodegeneration in Parkinson’s Disease

Parkinson’s disease (PD) is the second most common neurodegenerative disease, afflicting ~10 million people worldwide. Although several genes linked to PD are currently identified, PD remains primarily an idiopathic disorder. Neuronal protein α-synuclein is a major player in disease progression of b...

Full description

Bibliographic Details
Main Author: Andrei Surguchov
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Cells
Subjects:
Online Access:https://www.mdpi.com/2073-4409/10/2/407
id doaj-7d4b3d41519f47bcb64afe9e09bb35cb
record_format Article
spelling doaj-7d4b3d41519f47bcb64afe9e09bb35cb2021-02-17T00:02:41ZengMDPI AGCells2073-44092021-02-011040740710.3390/cells10020407Invertebrate Models Untangle the Mechanism of Neurodegeneration in Parkinson’s DiseaseAndrei Surguchov0Department of Neurology, University of Kansas Medical Center, Kansas City, KS 66160, USAParkinson’s disease (PD) is the second most common neurodegenerative disease, afflicting ~10 million people worldwide. Although several genes linked to PD are currently identified, PD remains primarily an idiopathic disorder. Neuronal protein α-synuclein is a major player in disease progression of both genetic and idiopathic forms of PD. However, it cannot alone explain underlying pathological processes. Recent studies demonstrate that many other risk factors can accelerate or further worsen brain dysfunction in PD patients. Several PD models, including non-mammalian eukaryotic organisms, have been developed to identify and characterize these factors. This review discusses recent findings in three PD model organisms, i.e., yeast, Drosophila, and <i>Caenorhabditis elegans</i>, that opened new mechanisms and identified novel contributors to this disorder. These non-mammalian models share many conserved molecular pathways and cellular processes with humans. New players affecting PD pathogenesis include previously unknown genes/proteins, novel signaling pathways, and low molecular weight substances. These findings might respond to the urgent need to discover novel drug targets for PD treatment and new biomarkers for early diagnostics of this disease. Since the study of neurodegeneration using simple eukaryotic organisms brought a huge amount of information, we include only the most recent or the most important relevant data.https://www.mdpi.com/2073-4409/10/2/407neurodegenerationprotein aggregationprotein sortingalpha-synucleinvesicular traffickingfolate
collection DOAJ
language English
format Article
sources DOAJ
author Andrei Surguchov
spellingShingle Andrei Surguchov
Invertebrate Models Untangle the Mechanism of Neurodegeneration in Parkinson’s Disease
Cells
neurodegeneration
protein aggregation
protein sorting
alpha-synuclein
vesicular trafficking
folate
author_facet Andrei Surguchov
author_sort Andrei Surguchov
title Invertebrate Models Untangle the Mechanism of Neurodegeneration in Parkinson’s Disease
title_short Invertebrate Models Untangle the Mechanism of Neurodegeneration in Parkinson’s Disease
title_full Invertebrate Models Untangle the Mechanism of Neurodegeneration in Parkinson’s Disease
title_fullStr Invertebrate Models Untangle the Mechanism of Neurodegeneration in Parkinson’s Disease
title_full_unstemmed Invertebrate Models Untangle the Mechanism of Neurodegeneration in Parkinson’s Disease
title_sort invertebrate models untangle the mechanism of neurodegeneration in parkinson’s disease
publisher MDPI AG
series Cells
issn 2073-4409
publishDate 2021-02-01
description Parkinson’s disease (PD) is the second most common neurodegenerative disease, afflicting ~10 million people worldwide. Although several genes linked to PD are currently identified, PD remains primarily an idiopathic disorder. Neuronal protein α-synuclein is a major player in disease progression of both genetic and idiopathic forms of PD. However, it cannot alone explain underlying pathological processes. Recent studies demonstrate that many other risk factors can accelerate or further worsen brain dysfunction in PD patients. Several PD models, including non-mammalian eukaryotic organisms, have been developed to identify and characterize these factors. This review discusses recent findings in three PD model organisms, i.e., yeast, Drosophila, and <i>Caenorhabditis elegans</i>, that opened new mechanisms and identified novel contributors to this disorder. These non-mammalian models share many conserved molecular pathways and cellular processes with humans. New players affecting PD pathogenesis include previously unknown genes/proteins, novel signaling pathways, and low molecular weight substances. These findings might respond to the urgent need to discover novel drug targets for PD treatment and new biomarkers for early diagnostics of this disease. Since the study of neurodegeneration using simple eukaryotic organisms brought a huge amount of information, we include only the most recent or the most important relevant data.
topic neurodegeneration
protein aggregation
protein sorting
alpha-synuclein
vesicular trafficking
folate
url https://www.mdpi.com/2073-4409/10/2/407
work_keys_str_mv AT andreisurguchov invertebratemodelsuntanglethemechanismofneurodegenerationinparkinsonsdisease
_version_ 1724265913175244800